Centene Co. (NYSE:CNC) Director Thomas Greco Acquires 17,000 Shares of Stock

Centene Co. (NYSE:CNC) Director Thomas Greco bought 17,000 shares of the company’s stock in a transaction on Wednesday, December 18th. The stock was bought at an average price of $59.75 per share, for a total transaction of $1,015,750.00. Following the completion of the purchase, the director now directly owns 19,309 shares in the company, valued at approximately $1,153,712.75. This represents a 736.25 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

Centene Price Performance

Shares of NYSE CNC opened at $59.71 on Friday. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $81.42. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market cap of $30.15 billion, a PE ratio of 10.37, a P/E/G ratio of 0.78 and a beta of 0.46. The business has a 50-day simple moving average of $61.01 and a two-hundred day simple moving average of $68.29.

Institutional Trading of Centene

Several large investors have recently bought and sold shares of the stock. Park Place Capital Corp grew its stake in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after purchasing an additional 357 shares during the last quarter. WR Wealth Planners LLC increased its holdings in Centene by 41.4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after buying an additional 137 shares during the period. Chris Bulman Inc purchased a new position in Centene during the 2nd quarter worth approximately $33,000. Crewe Advisors LLC lifted its stake in Centene by 174.3% during the 2nd quarter. Crewe Advisors LLC now owns 683 shares of the company’s stock valued at $45,000 after acquiring an additional 434 shares during the period. Finally, Private Trust Co. NA increased its stake in shares of Centene by 75.3% in the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock worth $58,000 after acquiring an additional 332 shares during the period. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analyst Ratings Changes

CNC has been the topic of several research analyst reports. UBS Group raised Centene from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $79.00 to $80.00 in a research note on Friday, December 13th. StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th. Truist Financial decreased their price objective on Centene from $89.00 to $84.00 and set a “buy” rating for the company in a report on Friday, December 13th. Robert W. Baird dropped their target price on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. Finally, Barclays upped their price target on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research report on Friday, December 13th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, Centene has an average rating of “Moderate Buy” and an average price target of $80.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.